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1. Introduction 
The aim of this chapter is to present a review of the main protein kinases involved in the 
signalling pathways between the stimulation of smooth muscle cell and the resulting 
dynamic contraction.   
As in striated muscle cells, contraction in smooth muscle cells (SMC) is primarily triggered 
by intracytosolic Ca2+ ([Ca2+]i) increase. However, by contrast with striated muscle, in SMCs 
[Ca2+]i increase generates contraction by activation of the myosin light chain kinase (MLCK) 
via the formation of the Ca2+-calmodulin-MLCK complex. Activated MLCK phosphorylates 
the 20kDa regulatory light chain (MLC20) of the thick filament. Phosphorylated MLC20 
allows myosin to bind to actin, and this phosphorylation is critical for SMC contraction, 
since its inhibition generally abolishes agonist-dependent contraction, whereas relaxation is 
induced by MLC20 dephosphorylation by myosin light chain phosphatase (MLCP). Hence, 
excitation-contraction coupling in SMCs critically depends on Ca2+-dependent MLCK 
activation and the balance of MLCK/MLCP activity. Moreover, it has been shown that these 
two major enzymes can be modulated by several protein kinases such as protein kinase A 
(PKA), protein kinase C (PKC) and Rho kinase (RhoK). As a consequence, these protein 
kinases indirectly modulate the activity of the thick filament of myosin. Additionally, actin-
myosin interaction can be modulated by proteins associated to the thin filament of actin 
such as caldesmon and calponin, which modulation depends on their phosphorylation by 
several protein kinases. It appears then that in SMCs, the excitation-contraction coupling is 
determined by interacting signalling pathways involving various protein kinases, so that the 
canonical MLCK/MLCP enzymatic balance is embedded in a complex network of protein 
kinases acting both on the thick and thin filaments of the contractile apparatus. The  chapter 
will present the functional structure of the contractile apparatus of SMC, and detail its 
activation by the Ca2+-calmodulin-MLCK complex and down regulation by MLCP, and the 
action of the main PK that have been shown to modulate the sensitivity of the contractile 
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apparatus to Ca2+. The resultant behaviour of the SMC stimulated by contractile agonists not 
only depends on the structure of the regulatory network that modulates the contractile 
apparatus but also on the dynamics of the reactions. Mathematical modelling of this 
signalling network is of great help to decipher how different protein kinases involved in this 
network participate to the time-dependent behaviour of the contractile system. Several 
theoretical models have been developed in this sense. The chapter will present the general 
principles of these models, their predictions and how they help in understanding the role of 
PK in the time course of the contractile response of SCMs. 
In this chapter, examples are taken from airway smooth muscle cells, though this chapter is 
not limited to this tissue, and describes general mechanisms present in other SMC types. 
2. Ca
2+
 signalling and the contractile apparatus 
2.1 Ca
2+
 signalling in airway smooth muscle cells 
In smooth muscle cells, as in heart and skeletal muscle, [Ca2+]i is the primary intracellular 
messenger that generates contraction. Stimulation of smooth muscle cells by contractile 
agonists results in an increase in [Ca2+]i, which in turn activates the contractile apparatus. 
However, the mechanisms by which Ca2+ stimulates the formation of actin-myosin bridges 
critically differ in smooth muscle cells from striated muscle cells (see below). Though Ca2+ 
signalling is not primarily triggered via direct protein kinase activation by contractile agonists, 
several agents that contribute to the Ca2+ signal can be modulated by protein kinases and, on 
the other hand, activation of several protein kinases involved in the modulation of the 
contractile apparatus is Ca2+ sensitive. Hence, this section will present a general overview of 
the mechanisms of Ca2+ signalling in smooth muscle cells, including in airways. 
[Ca2+]i value in basal conditions is maintained around 100 nM, a low value compared to 
extracellular medium, around 1-2 mM, and intracellular organelles like the sarcoplasmic 
reticulum, by active mechanisms of Ca2+ efflux through the plasma membrane and Ca2+ 
pumping into intracellular Ca2+ stores. When cells are stimulated, [Ca2+]i is increased via 
different mechanisms which relative importance depends on smooth muscle cell types 
and/or contractile agonists. Basically, the general mechanisms of [Ca2+]i increase involve 
either intracellular Ca2+ influx or intracellular Ca2+ release from internal Ca2+ stores, or both 
(Sanders, 2001; Somlyo et al., 1994). Voltage-dependent Ca2+ occurs via L-type voltage-
operated Ca2+ channel (VOC). Normal resting membrane potential in airway myocytes is 
around -60 mV (Roux et al., 2006), and is highly dependent on basal K+ conductance. Some 
K+ channels are active at rest, and contribute to the resting K+ conductance and hence 
resting membrane potential. Closure of K+ channels tends to depolarize the plasma 
membrane which in turn induces extracellular Ca2+ influx via VOC. By contrast, additional 
activation of K+ channels tends to hyperpolarize the plasma membrane, to inhibit VOC-
dependent Ca2+ influx and hence to induce relaxation. Voltage-dependent Ca2+ influx and 
subsequent contraction is called the electromechanical coupling. In parallel to voltage-
operated Ca2+ entry, Ca2+ influx can be generated by voltage-independent membrane 
channels. Receptor-operated channels can be opened by direct binding of the agonist on the 
membrane receptor, like P2X purinergic receptors (Mounkaila et al., 2005). Another voltage-
independent source of Ca2+ entry is Ca2+ influx through store-operated Ca2+ channels (SOC). 
These channels are activated by emptying of intracellular Ca2+ stores (Marthan, 2004).  
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The other origin of [Ca2+]i increase is Ca2+ release from intracellular organelles (Sanders, 2001). 
The major one from which Ca2+ is released upon contractile stimulation is the sarcoplasmic 
reticulum (SR). Ca2+ release from the sarcoplasmic reticulum, with internal Ca2+ concentration 
in the millimolar range, occurs via two main types of sarcoplasmic receptors, the inositol-
trisphosphate receptors (InsP3Rs) and the ryanodine receptors (RyRs). InsP3Rs are activated by 
InsP3, which is produced from phosphatidylinositol phosphate by phospholipase C (PLC) 
upon stimulation by contractile agonists (Roux et al., 1998). Activation of contraction via 
primary InsP3 production and InsP3R-operated Ca2+ release, a consequence of enzymatic 
activation of PLC, is called the pharmacomechanical coupling, in opposition with the 
electromechanical coupling described above. RyRs are physiologically activated by an increase 
in Ca2+ concentration on the cytosolic face of the RyR, or by direct mechanical coupling 
between L-type VOC, and it has  been shown that cyclic ADP ribose is a co-agonist of RyR 
(Prakash et al., 1998). RyR activation by Ca2+ self-amplifies [Ca2+]i increase, whatever its initial 
mechanism. This Ca2+-induced Ca2+ release (CICR), however, is not observed in all smooth 
muscle cells. In human bronchial smooth muscle, for example, RyR, though present and 
functional, do not participate in the acetylcholine-induced Ca2+ response (Hyvelin et al., 2000a).  
Basal maintenance of low [Ca2+]i and Ca2+ removal form the cytosol upon and after 
stimulation is due to active mechanisms that either extrude Ca2+ in the extracellular medium 
or uptake Ca2+ into intracellular Ca2+ stores. Ca2+ extrusion is mainly due to the activity of 
the plasma membrane Ca2+ ATPase (PMCA), and the Na+-Ca2+ exchanger (NCX) (Sanders, 
2001).The main mechanisms of Ca2+ uptake from the cytosol are  Ca2+ pumping back into the 
SR by sarcoendoplasmic Ca2+ ATPase (SERCA), Ca2+ uptake into the mitochondria. Also, 
several Ca2+-binding proteins can buffer cytosolic Ca2+ and hence decrease [Ca2+]i (Gunter et 
al., 2000; Roux et al., 2004). 
The Ca2+ signal is not only the overall increase in the cellular Ca2+ pool and subsequent 
[Ca2+]i but also, and most importantly, the pattern of the dynamic change in [Ca2+]i. Indeed, 
the time-dependent variation in the shape of [Ca2+]i is the actual “Ca2+ signal”, since Ca2+ 
binding to signalling protein, e. g., calmodulin, depends on cytosolic Ca2+ concentration. 
Overall [Ca2+]i measurements generally show a transient increase in [Ca2+]i (Ca2+ peak) 
followed by a progressive decay to a steady-state value (Ca2+ plateau) and/or by Ca2+ 
oscillations (Bergner et al., 2002; Hyvelin et al., 2000b; Kajita et al., 1993; Liu et al., 1996). 
Changes in [Ca2+]i are not uniform within the cytosol, and studies have evidenced the role of 
local change in Ca2+ signalling (Prakash et al., 2000). Ca2+ signalling should hence be defined 
as spatiotemporal changes in [Ca2+]i, from which depends the activity of the contractile 
apparatus, and other cell functions. The shape of this Ca2+ signal critically depends on the 
dynamics of Ca2+ fluxes between intra- and extracellular media and also between 
intracellular Ca2+ compartments. The dynamic relationship between the calcium signal and 
MLCK activity and its consequence on force development will be discussed in more detail in 
the section “Theoretical modelling of PK and ASMC contraction”. 
2.2 Smooth muscle contractile apparatus 
2.2.1 Components and general organization 
The contractile apparatus of smooth muscle is basically constituted of thick filaments of 
myosin II and thin filament of actin and associated proteins, the thin/thick filament ratio 
www.intechopen.com
 
Protein Kinases 
 
290 
being about 20/1 to 30/1 (Kuo et al., 2003; Somlyo et al., 1983). These filaments are not 
organized in sarcomeres and do not form well individualized myofibrils. Thick filaments 
are anchored on dense bodies in the cell and dense area on the plasma membrane and actin 
filaments are positioned between thick filaments. Dense bodies and filaments are connected 
by non-contractile intermediate filaments that constitute an intracellular network.  
Thick filaments are 1.5 µm long and 12-14 nm in diameter, and are composed of 
polymerized monomers of myosin. Each monomer of myosin is formed by the association of 
2 identical heavy chains (MHC) complexed to 2 pairs of light chains (MLC). Each of the 2 
heavy chains has a C-terminal extended ┙-helix twisted to form a single tail and an N-
terminal head. 4 isoforms of MHC have been described in smooth muscle cells, 
corresponding to 4 alternatively-spliced variants derived from the single smooth muscle 
myosin heavy chain gene MYH11, differing in their amino-terminal and carboxy-terminal 
portions (Hong et al., 2011). Polymerized and monomeric myosins are in equilibrium and 
the stimulation of the myocyte increases myosin polymerization. The distal portion of the 
myosin head has the ATPase enzymatic activity required for its motor function, and a 
binding site for actin. A pair of light chains, a 17 kDa one and a 20 kDa one, is complexed 
with each of the head of the myosin heavy chain.  The role of MLC17 is unclear, and it is 
thought to contribute to the stability of the molecule of myosin. Phosphorylation of the so-
called regulatory MLC20 is required for actin-myosin binding, and hence 
phosphorylation/dephosphorylation of MLC20 regulates actin-myosin cross bridge and 
contraction. 2 residues, located in the amino-terminal portion of the protein, threonine 18 
and serine 19, can be phosphorylated by MLCK. The major site of phosphorylation by 
MLCK in intact myocyte is ser19, though thr18 can also be phosphorylated by MLCK. It has 
been shown that Rho kinase can also directly phosphorylate MLC20, but, at least in airway 
smooth muscle, Rho kinase regulates phosphorylated/dephosphorylated MLC20 ratio by 
acting on MLCP (Mbikou et al., 2011). It has been shown that PKC may also phosphorylate 
MLC20 but on different residues, serine 1, serine 2 and threonine 9 (Barany et al., 1996). 
However, it is generally admitted that PKC contributes to smooth muscle contraction 
mainly via MLCP inhibition. 
Smooth muscle thin filaments are formed by a double helix of F-actin complexed with 
tropomyosin, caldesmon and calponin. Globular smooth muscle ┙-actin molecules assemble 
into filamentous polymers of F-actin, and 2 parallel strands of F-actin rotate on each other to 
form a double helix structure. F-actin filaments are about 1 µm long and 5-7 nmn in 
diameter. As in striated muscle, tropomyosin binds to F-actin in the furrow formed by the 
double helix of actin, and contributes to actin filament stabilization (Shah et al., 2001). In 
contrast with striated muscle, here is no troponin on the thin filament of actin in smooth 
muscle, and other proteins, caldesmon and calponin, are associated with actin. Caldesmon 
and calponin are regulatory proteins that can be phosphorylated by several kinases and 
their phosphorylation modulates the formation of the actin-myosin bridge. Regulation of 
contraction by caldesmon and calponin is detailed below. 
2.2.2 Actin-mysosin bridge cycling 
Basically, muscle contraction is based on cycling attachment and detachment between thick 
filaments of myosin and thin filaments of actin. Interaction between actin and myosin, 
which corresponds to the formation of the actin-myosin crossbridge, is triggered by the 
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head of myosin. As seen above, in smooth muscle, phosphorylation of MLC20 is the key 
event that allows the formation of the actin-myosin bridge, a step required for contraction to 
occur (Harnett et al., 2003; Wingard et al., 2001). MLC20 phosphorylation induces a 
conformational change of the neck of myosin so that the head of myosin can bind to actin. 
This allows the rotation of the head of myosin responsible for the “sliding” of actin and 
myosin filaments. MLC20 phosphorylation also activates the ATPase activity of the myosin 
head, followed by actin and myosin detachment. When MLC20 remains phosphorylated all 
along the crossbridge cycle, crossbridge cycling is rapid, and associated with high ATP 
consumption.  However, sustained contraction can occur even if [Ca2+]i and subsequent 
MLC20 phosphorylation decrease (Mbikou et al., 2006), and this is generally attributed to the 
fact that if dephosphorylation of MLC20 occurs after the attachment of myosin on actin, 
crossbridge cycle goes on but at a slower rate, in particular in the stage where 
dephosphorylated myosin detaches actin. These maintained dephosphorylated crossbridges 
that cycle at a slow rate are termed latch-bridges. 
Hence, 2 types of crossbridges cycling can occur in smooth muscles, a fast, phosphorylated 
one (during which MLC20 remains phosphorylated) and a slow, partially dephosphorylated 
one (during which MLC20 is phosphorylated after actin-myosin attachment), and, 
accordingly, a 4-state model of the contractile apparatus has been proposed, initially by Hai 
and Murphy (Hai et al., 1988a). This model is presented in Figure 1. The first state 
corresponds to unbound actin and unphosphorylated MLC20, the second one to unbound 
actin and phosphorylated MLC20, the third one to actin bond to phosphorylated MLC20, and 
the fourth one to actin bond to dephosphorylated MLC20. Transition between state 1 and 2, 
and 3 and 4, is reversible and depends on MLC20 phosphorylation/dephosphorylation. 
Transition between state 2 and 3 is reversible and corresponds to the phosphorylated 
crossbridge cycling. Rate constant from state 1 to 4 is very slow, and it can be considered 
that transition from state 4 to 1 is almost irreversible. State 1-2-3-4-1 cycling corresponds to 
the latch-bridge cycling. 
A+M A+Mp
AMpAM
VDEPHO
S
VDEPHO
S
VPHOS
VPHOS
MLCP
MLCP
MLCKACTIVE
MLCKACTIVE
V+MPV-MPV+MV-M
 
Fig. 1. 4 state model of smooth muscle contractile apparatus. A, actin; M, unphosphorylated 
myosin; Mp, phosphorylated myosin; AM, unphosphorylated actin-myosin bridge; AMp, 
phosphorylated actin-myosin bridge; MLCK, myosin light chain kinase; MLCK, myosin 
light chain phosphatase; CaM, calmodulin. V, rate constants of the reactions. 
www.intechopen.com
 
Protein Kinases 
 
292 
The main enzyme by which MLC20 is phosphorylated is MLCK. Dephosphorylation of 
phosphorylated MLC20 is catalysed by MLCP. Though other enzymes can contribute to 
smooth muscle contraction, muscle contraction critically depends on the balance between 
MLCK and MLCP activity. 
2.3 Modulation of MLC20 phosphorylation: The MLCK/MLCP balance 
2.3.1 MLCK 
MLCK has a ubiquitous distribution and is present in non-muscular cells as well as cardiac, 
skeletal and smooth muscle cells. Several genes encode for distinct isoforms of MLCK. In 
humans, MYLK2 and MYLK3 genes encode for the MLCK isoforms expressed in skeletal 
and cardiac myocytes, respectively, and the smooth muscle isoform is encoded by the 
MYLK1 gene. This gene has 2 initiation sites generating a short isoform corresponding to the 
smooth muscle MLCK and a long isoform corresponding to nonmuscle MLCK. The domain 
structure of smooth muscle mammalian MLCK is shown in Figure 2. MLCK has 2 CaM-
binding domains, one at its aminoterminal portion, composed of 3 DFRxxL motifs, and the 
other at its carboxyterminal portion, before the IgT domain located at the N-terminus. The 
DFrxxL domain is also a binding site to actin, and Ca2+-CaM binding to this domain results 
in weakened actin binding. Some results suggest that Ig1/Ig2 domains bind to actin.  IgT 
domain is a binding site to myosin. The kinase domain is the catalytic portion of MLCK and 
includes a binding site for ATP and for MLC20. The role of the other domains is unknown 
(Hong et al., 2011). Hence, MLCK interacts with myosin on two sites. The catalytic core of 
MLCK interacts with the aminoterminal portion of MLC20, which allows phosphorylation 
MLC20. The IgT domain of MLCK may also interact with myosin at the head-neck junction. 
It is thought that IgT binding to myosin near the MLC20 increases the catalytic activity of 
MLCK. The concentration of MLCK is likely to vary from muscle to muscle, but typical 
values range from 1 to 8 µM, which is low compared with the typical concentration of 
myosin, classically ranging from 50 to 100 µM. 
DFRxxL prolin rich Ig1 Ig2 Fn Kinase CaM B IgT
CaM 
binding
function 
unknown
actin 
binding
function 
unknown
CaM 
binding
myosin
binding
MLC20 and 
ATP binding
N C
 
Fig. 2. Structural scheme of myosin light chain kinase (MLCK) and its different domains. 
In the absence of calmodulin (AcM) binding, the catalytic site (Kinase) is masked by the N-
terminal CaM binding and IgT domains and hence inactive. Binding of Ca2+-CaM complex 
induces a conformational change and unmasks the kinase domain hence active. 
The major substrate of MLCK in smooth muscle is the smooth muscle myosin, but recent 
results showed that non muscle myosin, which is also expressed in smooth muscle myosin, 
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can be a substrate for MLCK (Yuen et al., 2009). MLCK phosphorylates MLC20 on serine 19 
and, with lower enzymatic activity, on threonine 18 (Deng et al., 2001). MLCK activity is 
essential for airway smooth muscle contraction, as it has been evidenced by 
pharmacological inhibition of MLCK in rat trachea (Mbikou et al., 2006) and knockout mice 
(Zhang et al., 2010).  
The most important regulator of MLCK activity is the Ca2+-CaM complex. MLCK unbound 
to Ca2+-CaM is in an auto-inhibitory state. The IgT domain and the adjacent CaM binding 
domain constitute an auto-inhibitory sequence that masks the catalytic core. Ca2+-CaM 
binding to the auto-inhibitory site induces a conformational change. This displacement of 
the auto-inhibitory sequence unmasks the catalytic core and thereby reveals the enzymatic 
activity of MLCK. On the other hand, phosphorylation of MLCK on serine 512 by several 
kinases such as protein kinase A in the C-terminal CaM binding domain decreases MLCK 
affinity for the Ca2+CaM complex, thereby inactivating MLCK even in the presence of Ca2+, a 
mechanism responsible for MLCK desensitization (Stull et al., 1993). CaM is a rather small 
protein (16700 Da) consisting of a single polypeptidic chain of 148 to 149 aminoacids. 3 
distinct domains can be identified: an N-terminal domain, a central helix domain, and a C-
terminal domain. Both amino- and carboxy-terminal domain possesses 2 binding sites for 
Ca2+. The 4 sites have a high affinity for Ca2+, though the affinity of the C-terminal sites is 
higher. These sites have an EF-hand structure. Ca2+ binding induces a conformational 
change of the F-helix of the EF-hand motif. In this conformation CaM binds to several 
proteins and modulates their activity. Amongst almost 40 different proteins that have been 
shown to be regulated by CaM, the most important in smooth muscle are MLCK and CaM-
kinase II. 
2.3.2 MLCP 
MLCP is a holoenzyme composed of three subunits: the 38 kDa phosphatase catalytic 
subunit PP1c├, the 110 kDa regulatory subunit MYPT1, and a 20 kDa noncatalytic subunit, 
M-20, which role remains unclear (Hartshorne et al., 1999; Hartshorne et al., 1998). PP1c├ is a 
serine/threonine phosphatase that dephosphorylates MLC20 on serine 19 and threonine 18. 
Disruption of the quaternary structure of MLCP, either by dissociation of the regulatory 
subunit MYPT1 to PP1c or by disruption of the interactions between the three subunits, 
decreases MLCP activity toward MLC20 dephosphorylation.  
PP1c alone is capable of dephosphorylating the MLC20, but its activity is potentiated when 
complexed to MYPT1. Indeed, MYPT1s targets PP1c to its substrate, MLC20, and confers 
substrate specificity to the phosphatase. A recent study by crystallography has revealed a 
basic structure which potentiates the catalytic activity of the holoenzyme (Terrak et al., 2004). 
Structurally, MYPT1 subunit possesses a C-terminal leucine-zipper domain and a binding 
site of protein kinase G. Four N-terminal amino acids, KVKF, give a strong affinity for PP1c. 
MYPT1 also has six repeated domains of ankyrin, which serve as anchoring sites for protein-
protein interactions. Several kinases are able to phosphorylate MYPT1 at various sites: Rho 
kinase, MYPT kinase (also known as Zip-like kinase), integrin-like kinase, myotonic 
dystrophy kinase (DMPK). PKC also has been shown to phosphorylate ankyrin repeated 
domains and inhibit the interaction between MYPT1 and PP1c (Toph et al., 2000). In addition 
to this negative regulation of MLCP, MYPT1 phosphorylation is also associated with an 
upregulation. Recent studies have reported that protein kinases dependent on cyclic 
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nucleotides such as PKA and PKG are able to phosphorylate MYPT1 on serine 692, 695 and 
852. The S695 and S852 residues are adjacent to two residues, T696 and T853, that are 
phosphorylation sites of MYPT1 by RhoK. Phosphorylation at S695 by PKG or PKA 
prevents RhoK phosphorylation at S696 and vice versa (Wooldridge et al., 2004), and it is 
supposed that phosphorylation at S852 has a similar effect on T853 phosphorylation. Thus 
the phosphorylation of MYPT1 by PKA and PKG protein antagonizes the inhibition of 
MLCP induced by RhoK (Grassie et al., 2011). 
CPI-17 is another regulation pathway of MLCP activity (Ito et al., 2004). CPI-17 is a 17 kDa 
protein composed of 147 aminoacids that can inhibit the activity of the MLCP holoenzyme 
as well as that of isolated PP1c. Phosphorylation of CPI-17 at threonine 38 enhances its 
inhibitory potency about 1000 fold. The proposed mechanism is that CPI-17 binds at the 
PP1c active site, resulting in formation of a complex of MYPT1/PP1C/CPI-17 (Eto et al., 
2004). The major kinase responsible for in vivo CPI-17 phosphorylation is PKC, especially 
PKC┙ and PKC├. In vitro studies have shown that other kinases can phosphorylate CPI-17 at 
T38, including Rho kinase, protein kinase N (PKN), MYPT-kinase, integrin-like kinase and 
PKA (Ito et al., 2004). The scheme of the regulation of MLCP by kinase activity is given in 
Figure 3. 
MYPT1
PP1c M20PKC (-)
CPI-17
PKC 
RhoK
ILK
PAK
Zip-like K
PKN
(-)
RhoK
ILK
PAK
Zip-like K
ZipK
DMPK
Raf-1
(+) PKA PKG
MLCP holoenzyme
 
Fig. 3. Regulation of MLCP activity by protein kinases. DAP kinase, death-associated 
protein kinase;; DMPK, myotonic dystrophy protein kinase; ILK, integrin-linked kinase; 
MLCP, myosin light chain phosphatase; MYPT1, myosin phosphatase target subunit 1 of 
MLCP; M20, 20 kDa non-catalytic subunit of MLCP; PAK, p21-activated protein kinase; 
PKA, protein kianse A; PKC, protein kinase C; PKG, protein kinase G; PKN, protein kinase 
N; PLA2, phospholipase A2; PP1c, catalytic subunit of type1 protein phosphatase; RhoK, 
Rhokinase; ZipK; zipper-interacting protein kinase (adapted from (Hirano et al., 2003)). 
2.4 Thin filament-associated regulation of AM bridge cycling 
2.4.1 Caldesmon 
Caldesmon is a small protein of 87 kDa associated with the thin filaments of actin and 
involved in the regulation of smooth muscle contraction. Structurally, caldesmon possesses 
4 distinct domains and can bind to actin, tropomyosin, myosin and calmodulin.  The fourth 
domain located at the C-terminus is the most important since it is the binding domain to 
actin, to myosin and to Ca2+-binding proteins. Caldesmon interacts stoichiometrically with 
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tropomyosin to consolidate the actin filaments (Gusev, 2001), and contributes to the 
sensitivity of the myofilament to Ca2+. In the absence of Ca2+, the fourth domain interacts 
closely with actin and inhibits the ATPase activity. [Ca2+]i increase induces a conformational 
change of the actin-tropomyosin-caldesmon complex, allowing the ATPase activity of 
myosin. In addition, it allows an interaction between the thin and thick filaments as it is able 
to bind to both actin and myosin and this property seems to be involved in the sustained 
phase of the contractile response (Marston et al., 1991). In vitro studies have shown that 
caldesmon can be a substrate for several kinases (Kordowska et al., 2006). 
2.4.2 Calponin 
Calponin is a molecule of approximately 34 kDa related to the skeletal muscle troponin T. 
Calponin is present in smooth muscle at a concentration almost equivalent to that of 
tropomyosin. Calponin binding to F-actin disrupts actin-myosin interaction and hence 
negatively regulates the contraction of smooth muscle. Calponin inhibits the sliding of actin 
filament on myosin and the ATPase activity of myosin. The inhibitory effect of calponin is 
suppressed by high [Ca2+]i values, but only in the presence of calmodulin. Phosphorylation 
and dephosphorylation of calponin plays a key role in the regulation of smooth muscle 
contraction. Indeed, the inhibitory effect of calponin is abolished when calponin is 
phosphorylated by CaM kinase II or PKC, and is restored when calponin is 
dephosphorylated by phosphatase 2A (Winder et al., 1998; Winder et al., 1990). Based on 
these properties, 3 physiological roles have been identified for calponin: (1) maintenance of 
relaxation at rest when [Ca2+]i is low; (2) Ca2+-dependent contribution, involving 
calmodulin, to contraction when [Ca2+]i is increased and, (3) Ca2+-independent contribution 
to contraction via PKC-dependent phosphorylation. 
3. Role of protein kinases in the modulation of excitation-contraction 
coupling 
3.1 General overview 
3.1.1 Modulation of Ca
2+
 signalling 
Though protein kinases modulate smooth muscle contraction by acting mainly downstream 
of the Ca2+ signal, some of them have been shown to act upstream of the Ca2+ signal and 
regulate the activity of structures involved in Ca2+ signal encoding. It has been shown by in 
vitro studies that PKA can phosphorylate InsP3 receptors on serine 1755 and serine 1589 
(Ferris et al., 1991a). Studies using purified receptor protein reconstituted in liposomes have 
also evidenced that PKC and CaM kinase II can phosphorylate InsP3 receptors (Ferris et al., 
1991b). Ryanodine receptors also can be phosphorylated by PKA, PKC and CaM kinase II 
(Coronado et al., 1994). These phosphorylations may play an important role in smooth 
muscle physiology since Ca2+ release from SR plays a critical role in Ca2+ homeodynamics in 
airway myocyte (Ay et al., 2004; Roux et al., 2004). Indeed, contractile agonists such as 
acetylcholine act via InsP3 production but also activate PKC (Mbikou et al., 2006). On the 
other hand, PKA stimulation is a important pathway involved in bronchorelaxation since ┚2-
adrenergic stimulation, a major pharmacological treatment of asthma, acts mainly via Gs 
protein stimulation, adenylate cyclase activation, cAMP production and PKA activation 
(Anderson, 2006; Johnson, 2006). Extracellular ATP has also been shown to induce airway 
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relaxation via PKA activation (Mounkaila et al., 2005). Protein kinase may also modulate 
Ca2+ homeostasis by acting on voltage-dependent Ca2+ entry. As explained above, K+ 
channels critically contribute to the maintenance of myocyte membrane voltage, and it has 
been shown in vascular smooth muscle that PKA and PKC can phosphorylate several 
voltage-dependent K+ channels, Ca2+-activated K+ channels and ATP-dependent K+ 
channels, thus regulating the electromechanical coupling (Ko et al., 2008).  Phosphorylation 
by PKA activates these K+ channels and hence tends to hyperpolarize the plasma membrane 
and limit extracellular Ca2+ entry, whereas phosphorylation by PKC has an opposite effect. 
The effective contribution of these mechanisms in airway in unclear, since it has been shown 
that in airways activation of Ca2+-activated K+ channels does not seem to have a significant 
effect on ┚-adrenergic relaxation (Corompt et al., 1998). 
3.1.2 Modulation of the  Ca2+ sensitivity of the contractile apparatus 
The signalling pathways capable of modulating the contraction of a given Ca2+ signal 
constitute the modulation of the sensitivity of the contractile apparatus to Ca2+. As detailed 
previously, the importance of contraction depends on the balance between MLCK and 
MLCP activity, which is under control of several signalling pathways. In parallel with the 
canonical MLCK-dependent MLC20 phosphorylation, in several smooth muscles, MLC can 
be directly phosphorylated by Ca2+-independent kinases like ZIP kinases and Integrin-
linked kinase (ILK), which can also inhibit MLCP (Deng et al., 2002; Huang et al., 2006; 
Murthy, 2006; Niiro et al., 2001). Rho kinase, activated by small GTPase (Rho), which seems 
to be activated both by Ca2+-dependent and Ca2+-independent pathways, can phosphorylate 
directly MLC and, by inhibition of MLCP, indirectly increase MLC phosphorylation and hence 
regulate smooth muscle contraction (Bai et al., 2006; Murthy, 2006; Schaafsma et al., 2006). Also, 
contractile agonists may, in parallel to MLCK activation, inhibit MLCP activity. PKC can 
inhibit MLCP, and hence modulate contraction (Bai et al., 2006). By contrast, relaxant agonists, 
such as ┚2-agonists in airways, may act via MLCP activation and/or MLCK inhibition (Janssen 
et al., 2004; Johnson, 1998). So, in addition with the Ca2+-calmodulin-MLCK pathway, other 
Ca2+-dependent and independent enzymatic pathways regulate the contractile apparatus in 
smooth muscles, which status depends on the balance between MLCP/MLCK 
phosphorylation and dephosphorylation. Additionally, smooth muscle contraction can be 
modulated independently from MLC20 phosphorylation via caldesmon and calponin. The 
major kinases involved in smooth muscle contraction are listed below. 
3.2 RhoK 
Rho-associated kinase (Rho-kinase), originally identified as an effector of the small GTPase 
Rho, has been shown to play a major role in many processes including cell migration, 
neuronal polarisation, cytokinesis and cell contraction. It is a serine/threonine kinase 
structurally related to myotonic dystrophy kinase as there is 72% homology in the kinase 
domains. Different studies support the idea that Rho-kinase exists as a dimer resulting from 
parallel association through the coil-coil domain (Shimizu et al., 2003). There are two Rho- 
kinase members, Rho-kinase I/ROK┚/p160ROCK and Rho-kinase II /ROK┙/Rho kinase, 
which share 65% sequence identity and 95% sequence similarity at the amino acid level 
(Riento et al., 2003b). The kinase domain is highly conserved between these two proteins 
(83% identical), suggesting that they may have similar substrate specificity. The consensus 
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phosphorylation sequence for Rho-kinase is R/KXS/T or R/KXXS/T (X is any amino acid). 
The Rho-kinase protein is composed of three domains: a N-terminal kinase domain, a 
central coiled-coil domain containing a Rho binding site (RhoBD), and a C-terminal 
pleckstrin homology-like domain (PH-like domain) containing a Cys-rich region similar to 
the C1 domain of protein kinase C. The C-terminal region including the RhoBD plus the PH 
domain has been shown to directly interact with the kinase domain to inhibit its activity 
(Amano et al., 1999). The interaction between RhoGTP and the RhoBD releases this 
autoinhibition and thus activates the kinase (Ishizaki et al., 1996). In addition to Rho other 
small as GTPases such Rnd3/RhoE, Gem and Rad can bind Rho-kinase outside of the Rho-
binding region and inhibit its function (Komander et al., 2008; Riento et al., 2003a). Arachidonic 
acid has been also shown to activate Rho-kinase via its PH domain (Araki et al., 2001). 
Although both Rho-kinase I and Rho-kinase II proteins are ubiquitously expressed in most 
tissues, higher levels of Rho-kinase II are found in brain and muscles whereas higher levels of 
Rho-kinase I are found in non-neuronal tissues such as liver, lung and testis (Leung et al., 1996; 
Nakagawa et al., 1996). Functional differences have been reported between Rho-kinase I and 
Rho-kinase II. For instance Rho-kinase I seems to be essential for the formation of stress fibres, 
whereas Rho-kinase II seems important for phagocytosis and cell contraction, both being 
dependent on MLC phosphorylation (Wang et al., 2009; Yoneda et al., 2005). Binding tests 
revealed that RhoE preferentially binds Rho-kinase I, but not Rho-kinase II, whereas MYPT1 
binds only Rho-kinase II (Komander et al., 2008; Wang et al., 2009). 
There has been a great deal of interest in the involvement of the Rho/ROCK signalling 
pathway in excitation–contraction coupling (Iizuka et al., 1999; Mbikou et al., 2011; Yoshii et 
al., 1999). Activation of the Rho/Rho-kinase pathways is likely due to the stimulation of the 
G-coupled protein receptor.  Stimulation of M3 muscarinic receptors agonist for instance 
activates the Gq, G12 and G13 ┙-subunits which cause the cascade activation of GEFs, RhoA 
and Rho-kinase leading to Ca2+ sensitization (Hirano et al., 2004; Somlyo et al., 2003). It is 
well-known that Rho/Rho-Kinase signalling modulates Ca2+ sensitivity of the smooth 
muscle likely either by inhibition of the MLCP activity or by direct phosphorylation of the 
MLC20. Precisely, Rho-kinase has been shown to phosphorylate the MYPT1 subunit of the 
MLCP at two inhibitory sites, Thr696 and Thr853, by that causing the dissociation between 
the MLCP and MLC20 (Feng et al., 1999; Kawano et al., 1999; Kimura et al., 1996; Velasco et al., 
2002). Phosphorylation of MYPT1 by Rho-kinase alters the MYPT1-PP1c interaction, which 
decreases MLCP activity toward MLC20. Rho-kinase is also able to directly phosphorylate 
Ser19 and Thr18 in non-muscle cells (Ueda et al., 2002), but the direct contribution of Rho-
kinase to phospho-MLC20 levels in vivo is not yet proven. Moreover, Rho kinase exerts an 
inhibitory activity toward PP1c subunit of MLCP upon the phosphorylation of the latter (Eto 
et al., 1995; Eto et al., 1997). Taken together, the mechanisms triggered by Rho-kinase activity 
enhance the level of phosphorylated MLC20 and, consequently, myosin ATPase activity and 
therefore contraction. In vitro tests have shown that Rho-kinase is also able to phosphorylate 
CPI17 (MLCP inhibitor protein), thus inducing the inhibition of MLCP and thereby raising 
the level of phosphor MLC20 (Amano et al., 2010). 
3.3 PKC 
The protein kinase C (PKC) family is the largest serine/threonine-specific kinase family 
known. It embraces a large family of enzymes that differ in structure, cofactor requirements 
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and function (Nishizuka, 1995). Depending on their cofactor requirements, the homologous 
group of PKC can be divided into three groups as follows: the group of conventional (c)PKC 
isoforms (┙, ┚I, ┚II and ┛), that require Ca2+ and diacylglycerol (DAG) to become activated; 
the group of novel (n)PKC isoforms (├, ┝, ┞, ┠ and ┤) that require only DAG; and group of  
the atypical (a)PKC isoforms, namely ┞, ┡ and ┣ (the mouse homologue of human PKC┡), that 
require neither Ca2+ nor DAG. The general structure of a PKC molecule consists of a 
catalytic domain in N-terminal and a regulatory pseudosubstrate in C-terminal, both 
framing 3 distinct sites able to bind specifically ATP, Ca2+ or phosphatidyl serine. The 
pseudosubstrate region is a small sequence of amino acids that binds the substrate-binding 
cavity in the catalytic domain, thus keeping the enzyme inactive. The activity of PKC is 
controlled by its compartmentalization within the cell. All PKC family members possess a 
phosphatidylserine binding domain for membrane interaction. The expression and 
distribution of PKC isoforms is tissue- and species–specific. Some isoforms (e.g. PKC┙) are 
ubiquitously expressed in tissues whereas others seem to be restricted to certain tissues 
(Webb et al., 2000). In ASM, the protein and mRNA expression of PKC isoforms differs 
depending on the specie. In human trachealis for instance, there is expression of the 
conventional ┙, ┚I, and ┚II PKC isoforms as well as novel  (├, ┝, ┞, ┠) and atypical (┞) (Webb et 
al., 1997) while canine trachealis does not express the ┙ isoform and bovine ASM expresses 
the ┠-PKC variants (Webb et al., 2000). 
It is well known that the stimulation of a Gq protein-coupled receptor, for instance by 
cholinergic agonist, induces the elevation of the cytosolic Ca2+ concentration and the 
production of DAG by phospholipase C. Both Ca2+ and DAG bind to the C2 and C1 domain, 
respectively, and recruit PKC to the membrane (Bell et al., 1991; Huang, 1989). This 
interaction with the membrane results in release of the pseudosubstrate from the catalytic 
site and activation of the enzyme(Lester et al., 1990).  
PKC may modulate the sensitivity of the contractile apparatus to Ca2+, since it can inhibit 
MLCP activity. However, the effectiveness of PKC contribution to airway contraction 
remains controversial. PKC has been shown to be involved in force maintenance in human 
airways (Rossetti et al., 1995).  However, other studies do not implicate PKC in agonist-
induced Ca2+ sensitization and point to other effectors such as the small GTP-binding 
protein p21rho  (Akopov et al., 1998; Itoh et al., 1994; Otto et al., 1996; Yoshii et al., 1999). Our 
recent studies have shown that PKC contributes to the sustained phase, but not to the initial 
phase, of cholinergic-induced contraction in rat airways (Mbikou et al., 2006). 
3.4 PKA 
Cyclic-AMP-dependent protein kinase (PKA) is an ubiquitous mammalian enzyme which 
catalyzes Ser/Thr phosphorylation in protein substrates that in turn control a wide range of 
cellular functions including gene regulation, cell cycle, metabolism and cell death (Shabb, 
2001). This tetrameric holoenzyme comprises two catalytic (C) subunits that possess kinase 
activity and two inhibitory regulatory (R) subunits, each including two tandem cAMP 
binding domains, i.e. CBD-A and CBD-B (Johnson et al., 2001). cAMP is the essential second 
messenger that activates PKA (Berman et al., 2005; McNicholl et al.). In the absence of cAMP, 
the R-subunit and the C-subunit create a complex that blocks substrate access and thus 
prevents the kinase activity. cAMP binding to the R-subunits releases these inhibitory 
interactions and unleashes the C-subunit, allowing substrate phosphorylation. There are 
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three isoforms of C (C┙, C┚, and C┛) and two major isoforms of R (RI and RII) that are 
further distinguished into subforms (┙ and ┚) (Zhao et al., 1998). The physiological 
importance of these isozyme variations is not fully understood, but anchoring proteins 
(AKAPs) for RII give it a unique cellular distribution (Scott et al., 1994) RI and RII show 
sequence homology in their cAMP-binding and pseudosubstrate domains but differ 
extensively in their dimerization domains as well as in the sequence connecting the 
dimerization and pseudosubstrate domains. All known R-subunit isoforms share a common 
organization that consists of a dimerization domain at the NH2 terminus followed by an 
autoinhibitor site and two-tandem cAMP-binding domains noted CBD-A and B (Taylor et 
al., 2005). While the portion of the R subunit COOH-terminal to the inhibition site is 
responsible for high affinity binding of the C-subunit and cAMP, the remaining NH2 
terminus serves as an adaptor for binding to kinase anchoring proteins (Scott et al., 1994) 
and is responsible for in vivo subcellular localization and targeting of PKA. 
The ordered sequential mechanism of PKA activation is described as follows: cAMP binds 
first to CBD-B, making site CBD-A accessible to a second molecule of cAMP, which in turn 
causes the release of the active C-subunit (Kim et al., 2007; Su et al., 1995). In other words 
CBD-B functions as a gatekeeper for CBD-A, whereas the latter acts as the central controlling 
unit of the PKA system and provides the primary interfaces with the C-subunit (McNicholl 
et al.). The structures of the R-subunit in its active and inhibited states have also 
demonstrated that although CBD-A and CBD-B play clearly distinct roles in the activation of 
PKA, they both share similar allosteric features.  
PKA activation is closely dependent on the cytosolic cAMP level which is itself regulated by 
G proteins via an enzyme named adenylate cyclase. Stimulation of GPCRs, by muscarinic 
receptor agonist for instance, can rise up or drop off AMPC production depending on the 
type of GPCRs. Indeed, GPCRs that activate the G┙i subunits inhibit cAMP production 
whereas GPCRs that activate the G┙s subunits activate cAMP production through this 
specific sequence: 1) activated G┙s subunit interacts with the adenylate cyclase 2)  adenylate 
cyclase quickly converts ATP into cAMP, 3) AMPc molecule activate the PKA. Activation of 
PKA is involved in airway smooth muscle relaxation (Zhou et al., 1992), which may involve 
phosphorylation of a number of effector proteins that cause either reduction of [Ca2+]i 
and/or reduction of MLCK sensitivity to Ca2+-calmodulin (de Lanerolle et al., 1991). 
 Studies have demonstrated that cAMP-dependent signaling pathway activation prevents or 
reverses the ASM contraction indirectly, via the inhibition of InsP3 receptor (InsP3R) of the 
sarcoplasmic reticulum, reducing the [Ca2+]i. The InsP3R are responsible for mobilizing Ca2+ 
from sarcoplasmic reticulum in response to agonist binding. PKA has been shown to 
mediate the phosphorylation of the InsP3R which consequently reduces the ability of 
Inositol(l,4,5)triphosphate to release Ca2+ from membrane vesicles (Schramm et al., 1995). 
The mechanism by which PKA-induced phosphorylation decreases insP3-induced Ca2+ 
release has not been determined, but known consequences of receptor/channel 
phosphorylation include altered agonist affinity as well as altered function. 
3.5 CaMkinase II 
Calcium-calmodulin-dependent protein kinase II (CaMKII) is an oligomeric 
serine/threonine-specific protein kinase which belongs to a family of enzymes regulated by 
www.intechopen.com
 
Protein Kinases 
 
300 
the calcium-calmodulin complex similarly to the MLCK. Increases in the cytosolic Ca2+ 
concentration following the stimulation modulate the function of many intracellular 
proteins (Zhou et al., 1994). One of the most important intracellular acceptors of the Ca2+ 
signal is calmodulin (CaM), which exerts a modulating influence on the function of 
Ca2+/CaM-dependent protein kinases. Among them, the CaMKII shows a broad substrate 
specificity and has been thought to be a multifunctional protein kinase (Cohen et al., 1992; 
Colbran et al., 1989a; Colbran et al., 1989b). Four genes encode related but distinct isoforms 
of CaM kinase II (┙, ┚, ┛, and ├). It was originally isolated from brain tissues (Fukunaga et 
al., 1982) (Goldenring et al., 1983; Kuret et al., 1984) and preparations of CaM kinase II 
purified from rat forebrain consist of the ┙ (50 kDa) and ┚ (60 kDa) subunits whose cDNAs 
have been cloned and sequenced (Kolb et al., 1998). Non neuronal tissues express mostly the 
isoform ┛, and ├ but in such a low level that it makes difficult the purification of  the 
enzyme; so most biochemical and physical data on the enzyme have been established with 
CaMkinase II-┙ and -┚/┚’ from mammalian brain.  In smooth muscle, CaM kinase II was 
first isolated as caldesmon kinase (Ikebe et al., 1990b) with a molecular mass of the major 
subunit of 56 kDa. Isolated smooth-muscle CaM kinase II has enzymological properties 
similar to that of brain; however, smooth-muscle CaMKII is a tetramer according to its 
native molecular mass rather than a decamer or octamer as are the brain enzymes (Zhou et 
al., 1994). 
The CaMKII subunits are thought to assemble to holoenzyme through their C-terminal 
association domains (Fahrmann et al., 1998). The linear structure of the CaMKII core consists 
of a catalytic/autoregulatory domain (A) containing a variable region V1, a conserved linker 
(B), and an association domain that contains two highly conserved sequences  (C and D) as 
well as multiple variable regions (V2-V4). Function of each variable region has been 
identified as follows: V1 contains insert implicated in SR-membrane targeting; V2 possesses 
a functional nuclear localization signal, as well as a site of autophosphorylation; Insert X 
within V3 is rich in proline residues and conforms to a SH3-binding sequence. The variable 
regions are diversely expressed in the different subunits. For instance the ┙ and ├G isoforms 
are the smallest catalytically competent CaMKII products because they contain the A–D core 
sequences, but no inserts (Hudmon et al., 2002). The most prominent proteins 
phosphorylated by the Type II CaM kinase are its own subunits (Bennett et al., 1983; 
Kennedy et al., 1983; Miller et al., 1985; Miller et al., 1986). Some studies suggest that kinase 
activity decrease after autophosphorylation (Kuret et al., 1984; LeVine et al., 1985; Yamauchi 
et al., 1985) while others suggest that it increases (Shields et al., 1984) or becomes 
autonomous (Saitoh et al., 1985). Despite these discrepancies, the most accepted theory is 
that the autophosphorylation allows for the activation of the catalytic domain (Hanley et al., 
1987). The Ca2+-CaM complex interacts with and promotes autophosphorylation of each 
subunit of the CaMKII. 
The implication of the CAMKII in the artery smooth muscle reactivity has been extensively 
investigated whereas little is known regarding its role in the airways smooth muscle. In 
contracted cultured ASM cells from bovine, studies demonstrated that CaMKII is 
responsible for the phosphorylation of the MLCK (Stull et al., 1993). Biochemistry data 
showed that MLCK is phosphorylated by CaMKII (Hashimoto et al., 1990; Ikebe et al., 1990a) 
at a specific serine near the calmodulin-binding domain; and this phosphorylation brings 
about the reduction of the affinity of MLCK for the Ca2+CaM complex (Stull et al., 1990). In 
another hand the phosphorylation of MLCK by CaMKII have been shown to decrease the 
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Ca2+ sensitivity of MLC20 phosphorylation (Tansey et al., 1994; Tansey et al., 1992). Taken 
together, these findings would suggest that the net effect of the CaMKII is the relaxation of 
the ASM. However, enzymatic tests revealed two key elements which exclude this 
hypothesis: 1) the rate of phosphorylation of MLCK likely by the CaMKII is first of all 
slower than the rates of increase in cytosolic Ca2+ concentrations, 2) and also slower than the 
rate of phosphorylation of the MLC in intact tracheal smooth muscle cells in culture (Tansey 
et al., 1994). Therefore, the CaMKII activity is thought not to affect significantly the reactivity 
of the bovine ASM. Moreover, other studies showed that the CAMKII do not play a role in 
the profile of the contractile response upon stimulation in intact ASM from rat or cow (Liu et 
al., 2005; Mbikou et al., 2011; Sakurada et al., 2003). 
3.6 PI3K 
The phosphatidy inositol 3-kinases (PI3K) superfamily draws together all the enzymes 
capable of phosphorylating specifically the hydroxyl group of a membrane phospholipid 
called phosphatidyl inositol (PtdIns). Cloning approaches revealed the existence of eight 
distinct PI3K genes expressing eight isoforms in human and mouse genomes. Based on their 
domain structure, lipid substrate specificity and associated regulatory subunits, these 
isoforms have been divided into three main classes as follows: class I including p110┙, 
p110┚, p110├ and p110┛; class II including PI3K-C2┙, PI3K-C2┚ and PI3K-C2┛, and the class 
III consisting of the sole enzyme Vps34. The PI3K phosphorylates the PtdIns into four 
possible products, PtdIns(3)phosphate, PtdIns(3,4)biphosphate, PtdIns(3,5) biphosphate and 
PtdIns(3,4,5)triphosphate, which are involved in a wide range of cellular functions, 
including cell growth, proliferation, motility, differentiation, survival and intracellular 
trafficking (Fry, 2001; Fry, 1994; Katso et al., 2001; Rameh et al., 1999). 
Purified PI3K is a heterodimer of 85 and 110 kDa subunits (Carpenter et al., 1990; Fry et al., 
1992; Morgan et al., 1990; Shibasaki et al., 1991). Analysis of the primary sequence of p85 
reveals a multidomain protein which contains a number of non-catalytic domains, a Src 
homology region 3(SH3), and a region with significant sequence similarity to the product of 
the breakpoint cluster region gene BCR (Otsu et al., 1991). In vascular smooth muscle, PI3K 
appears to play a role in the regulation of contraction as experiments showed that the 
specific isoform PI3K-C2┙ is necessary for Rho/RhoKinase-dependent MLCP inhibition and 
consequently for the MLC20 phosphorylation and the contraction (Yoshioka et al., 2007). 
However, in the ASM, the PI3K does not regulate the agonist-induced contractile response 
(Mbikou et al., 2006). 
4. Theoretical modelling of PK and ASMC contraction 
4.1 Interest and general priniples 
Since the contractile pattern of SMC in response to contractile agonists not only depends on 
the structure of the regulatory network that modulates the contractile apparatus but also on 
the dynamics of the reactions, understanding of the mechanisms underlying this contractile 
profile is quite impossible by a non-mathematical intuitive approach. In the following 
sections, we will present the concepts of our recent mathematical modelling of isometric 
contraction and force development in airway smooth muscle cells based on the 4-state latch 
bridge model (Hai et al., 1988a) and upgraded by the unique description of MLCK and 
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MLCP regulatory pathways (Fajmut et al., 2008; Fajmut et al., 2005a; Fajmut et al., 2005b; 
Fajmut et al., 2005c; Mbikou et al., 2011; Mbikou et al., 2006). 
The latch state was first described by the mathematical model by Hai and Murphy in 1988 
(Hai et al., 1988a). They introduced the model of isometric contraction based on the 4-state 
kinetic scheme of actomyosin crossbridges, in which to actin bound and unbound to myosin 
(phosphorylated and dephosphorylated) represent four different states. Even nowadays, 
that model represents the reference in modelling of smooth muscle contraction.  
Huxley (Huxley, 1957) pioneered the modelling of smooth muscle contraction. His model 
from 1957 was based on the sliding filament theory. Until the occurrence of Hai and 
Murphy's model in 1988 (Hai et al., 1988b), relatively small number of models of smooth 
muscle contraction was developed compared to striated muscles. In 1986 Gestrelius and 
Börgström (Gestrelius et al., 1986) introduced new concepts in modelling. They first 
considered viscoelastic properties of the filaments and the cytoskeleton. The later model and 
Huxley's model enabled the study of nonisometric contraction and took into account mostly 
the dynamics and mechanics of the filaments and myosin crossbridges. Although the 
original Hai and Murphy's model (Hai et al., 1988a) enabled only the prediction of isometric 
force its advantage was in considering the regulatory mechanisms that drive smooth muscle 
contraction. Several authors have later upgraded it to enable the prediction of nonisometric 
contraction. In 1997 Yu et al. (Yu et al., 1997) expanded it to simulate the nonisometric 
contractions of smooth muscles, added length dynamics and assumed length-dependent 
bonding and unbonding rates to be distributed according to the Gaussian distribution. In 
1999 Fredberg et al. (Fredberg et al., 1999) and Mijailovich et al. (Mijailovich et al., 2000) 
integrated the latch regulation scheme of Hai and Murphy with Huxley’s sliding filament 
model of muscle contraction for the studies of the effects of length fluctuations on the 
dynamically evolving cross-bridge distributions, simulating those that occur in airway 
smooth muscle during breathing. The later model has been recently upgraded by simple 
description of Ca2+-dependent regulation of MLCK activity (Bates et al., 2009; Wang et al., 
2008). Our approach in the modelling of smooth muscle contraction is to upgrade the 4-state 
kinetic description of Hai and Murphy (Hai et al., 1988a) with the signalling pathways that 
regulate the MLC phosphorylation and dephosphorylation. This was for a long time the 
missing part in the modelling of smooth muscle contraction. 
Development of force in smooth muscles is achieved by interactions between myosin cross-
bridges and actin filaments. To describe theses interactions Hai and Murphy proposed a 
kinetic scheme shown in Figure 1 (Hai et al., 1988a). The scheme was later upgraded by 
Rembold and Murphy (Rembold et al., 1990) with the consideration of the attachment of 
dephosphorylated myosin to actin with a very slow rate. Many authors ignore this 
interaction, since the rate of attachment of dephosphorylated myosin is 150-fold lower than 
that of phosphorylated myosin (0.002 s-1 and 0.3 s-1, respectively) (Trybus, 1996). In our 
studies we consider it in the modelling (Fajmut et al., 2008; Fajmut et al., 2005a; Mbikou et al., 
2011; Mbikou et al., 2006).   
The four different states of the myosin cross-bridges are presented in Figure 1. : A+M - 
detached, dephosphorylated, A+MP - detached, phosphorylated, AMP - attached, 
phosphorylated, and AM - attached, dephosphorylated, the last one termed also a latch 
bridge. The corresponding reaction velocities of phosphorylation/dephosphorylation and 
attachment/detachment of myosin cross bridges, the relevant variables of mathematical 
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modelling, are indicated together with sites of action of enzymes MLCK and MLCP 
responsible for phosphorylation and dephosphorylation of MLCs, respectively. In the 
model, the magnitude of stress in smooth muscles is proportional to the concentration of 
myosin cross-bridges associated with actin filaments (AMP and AM), whereby myosin 
cross-bridges in the state AMP generate stress and cross-bridges in the state AM maintain 
stress in smooth muscles. v are either the velocities of  crossbridge attachment/detachment 
or the velocities of phosphorylation/ dephosphorylation, which are regulated by MLCK and 
MLCP. 
Hai and Murphy's model considered a very simple semi-theoretical description of the Ca2+-
dependent MLCK activation, and thus first coupled Ca2+ signalling pathway with the 
contraction. In this chapter we will present an upgrade from that model in the sense of 
purely theoretical and more detailed description of Ca2+-dependent MLCK activation and 
functioning as well as MLCP regulation of force development. Our new concepts will be 
compared with the old ones. As a basic model scheme, we take the four-state model, in 
which we incorporate explicitly the description of both enzymatic reactions. The activity of 
MLCK is under the influence of transmitting Ca2+ signal and, hence, Ca2+ directly affects the 
force development. On the other hand, the action of MLCP is considered either independent 
of other signalling pathways or being under influence of Rho-kinase (RhoK), which 
phosphorylates MLCP and regulates its activity and catalytic properties. 
4.2 Modelling of MLCK activity 
According to the generally accepted view, MLCK is activated by the Ca2+-CaM complex 
(Kamm et al., 2001). In general, an increase in [Ca2+]i is considered to initiate the binding of 
four Ca2+ ions to CaM, which is finally followed by association of complex Ca4CaM with 
MLCK (Dabrowska et al., 1982; Smith et al., 2000). In this chapter we will present three 
different approaches to deal with interactions between Ca2+, CaM and MLCK: a three-state 
model proposed by Kato et al. in 1984 (Kato et al., 1984), our eight-state model proposed by 
Fajmut et al. in 2005 (Fajmut et al., 2005b) and a semi-theoretical approach proposed by 
Rembold and Murphy in 1990 (Rembold et al., 1990). The kinetic scheme of a three-state 
model is presented in Figure 4.  
CaM Ca4CaM Ca4CaM·MLCK
4Ca2+
4Ca2+
MLCK
MLCK  
Fig. 4. The three-state kinetic scheme of MLCK activation proposed by Kato et al. (Kato et 
al., 1984). 
It assumes four independent and equivalent Ca2+ binding sites on CaM and considers a 
minimum number of possible states for CaM in the activation of MLCK. According to the 
kinetic scheme, MLCK is activated in two steps. The first step assumes simultaneous 
binding of four Ca2+ ions to CaM. In the second step, the intermediate complex of CaM with 
four Ca2+ ions bound (Ca4CaM) is associated with MLCK. The final product Ca4CaM-MLCK 
represents the active form of MLCK in the sense that it is able to phosphorylate MLCs. It 
should be noted, that Kato’s kinetic scheme (Kato et al., 1984) (Figure 4) reflects a somewhat 
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older and simplified view on the interactions between Ca2+, CaM and MLCK. Newer 
experimental studies show that not only Ca4CaM complex but also Ca2CaM complexes and 
Ca2+-free CaM interact with MLCK (Bayley et al., 1996; Johnson et al., 1996). It has been also 
shown that CaM and MLCK can interact without the presence of Ca2+ (Wilson et al., 2002) 
and that the velocity of Ca2+ binding to CaM is different with respect to N and C terminals 
on CaM (Brown et al., 1997; Johnson et al., 1996; Minowa et al., 1984; Persechini et al., 2000). 
CaM
Ca2(N)CaM
CaM·MLCK
Ca4CaM
MLCK
MLCK
2Ca2+
MLCK
2Ca2+
2Ca2+ 2Ca2+
k
-6
2Ca2+
2Ca2+
2Ca2+
2Ca2+
2Ca2+
Ca2(C)CaMCa2(C)CaM·MLCK
Ca2(N)CaM·MLCK
Ca4CaM·MLCK
 
Fig. 5. The eight-state kinetic scheme of MLCK activation proposed by Fajmut et al. 
(Fajmut et al., 2005a). 
On the basis of these experimental findings we proposed more detailed and profound 
kinetic model of MLCK activation that considers either six (Fajmut et al., 2005c) or eight 
(Fajmut et al., 2005a) different states of CaM with respect to binding sites for Ca2+ on C and 
N terminals and a binding site for MLCK. The corresponding eight-state kinetic scheme is 
presented in Figure 5.  
Binding reactions and reaction components involved can easily be recognised from the 
scheme. The complex Ca4CaM·MLCK represents the active form of MLCK and can be 
applied in the 4-state kinetic scheme of force development as indicated in Figure 1. 
In contrast to theoretical models of MLCK activation described here, a semi-theoretical 
approach was proposed by Hai and Murphy (Hai et al., 1988a). This approach was based on 
the expression fitted to the experimentally determined dependence of MLC phosphorylation 
on [Ca2+]i. The corresponding expression was built into the mathematical model of force 
development proposed by them (Hai et al., 1988a). The predictions of all abovementioned 
models for the steady state relative amount of the active MLCK (A), i.e., the ratio between 
Ca4CaM·MLCK and total MLCK versus [Ca2+]i, are presented in Figure 6.  
From the comparison of the model results (lines on the left panel) with the measurements 
(open circles) (Geguchadze et al., 2004) in Figure 6 one can conclude that predictions of the 
eight-state model (Fajmut et al., 2005a) (full line), most properly describes the process of 
MLCK activation. The other two models give either too sensitive (dotted line) (Rembold et 
al., 1990) or too insensitive (dashed line) (Kato et al., 1984) responses to [Ca2+] and they also  
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Fig. 6. Model prediction of MLCK activation.  Left panel: Relative amount of the active 
MLCK (A) in dependence on [Ca2+] according to: semi-theoretical approach by Rembold and 
Murphy (Rembold et al., 1990) (dotted line); eight-state model by Fajmut et al. (Fajmut et al., 
2005a) (full line); three-state model by Kato et al. (Kato et al., 1984) (dashed line). 
Experimental results of Geguchadze et al. (Geguchadze et al., 2004) (open circles). Right 
panel: The corresponding steady state force dependencies on [Ca2+] according to: Rembold 
and Murphy (Rembold et al., 1990) (curve 1); Fajmut et al. (Fajmut et al., 2005a) (curve 2); 
Kato et al. (Kato et al., 1984) (curve 3).  
do not have strong support by other experimental evidence (Gallagher et al., 1993; 
Geguchadze et al., 2004). The corresponding steady state force dependency on [Ca2+] (right 
panel) shows similar behaviour. Rembold and Murphy's model gives sensitive and Kato's 
model gives insensitive response to [Ca2+] and again don't have a strong support by 
experiments (Sieck et al., 1998). These findings speak in favour of the necessity for more 
complex description of interactions between Ca2+, CaM and MLCK in Ca2+-signal 
transduction pathway. Another important property, which has not been implicated in this 
steady state analysis, is time dependency. In the past the interactions between Ca2+, CaM 
and MLCK were considered as very fast (Kasturi et al., 1993; Torok et al., 1994) and thus 
modelled as being in the steady state. The reason for that were the results obtained in in 
vitro experiments, which exhibited very fast kinetics between Ca2+, CaM and MLCK. 
However, experiments from 2001 performed by Wilson et al. (Wilson et al., 2002) revealed 
that this might not be the case in vivo. Their experiments showed that at low [Ca2+]i  MLCK 
is present in complexes with Ca2+-free CaM as well as with Ca2CaM, in which Ca2+ is bound 
to the C-terminal of CaM (Wilson et al., 2002). It has been suggested that this is a 
consequence of the increased affinity of CaM for Ca2+ by the presence of MLCK in the 
complex (Wilson et al., 2002). In accordance with these findings the Ca2+-CaM activation of 
MLCK appears at sufficiently high Ca2+ levels, when in addition to the C-terminal binding 
sites, the N-terminal binding sites for Ca2+ on CaM are saturated. However, the transition 
from CaM-MLCK and Ca2CaM·MLCK complexes is much slower compared to the transition 
from Ca2+- and MLCK- free CaM state. Our model simulations show for typical 
physiological total amounts of CaM and MLCK (10 µM and 2 µM, respectively) in smooth 
muscle cells that for [Ca2+]i = 0.3 µM approximately one third of MLCK is in complexes with 
Ca2CaM, one third is Ca2+-CaM-free and one third is in active form. Moreover, the half 
saturation time for achieving the final active MLCK form for [Ca2+]i = 0.1 µM is 1.5 s and for 
[Ca2+]i = 0.5 µM it is 0.5 s. These results of the eight-state model show that the processes of 
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activation/deactivation of MLCK are not as fast as proposed by earlier models (Kato et al., 
1984) and some in vitro experiments on isolated CaM and MLCK (Kasturi et al., 1993; Torok 
et al., 1994). Moreover, the half-saturation time of MLCK activation/deactivation is of the 
same order of magnitude as the typical periods of oscillatory Ca2+ signals in smooth muscle 
cells (Mbikou et al., 2006; Perez et al., 2005), thus the processes of MLCK activation 
significantly contribute to decoding of oscillatory Ca2+ signal into a rather steady developed 
force already at the cellular level (Fajmut et al., 2008; Fajmut et al., 2005b; Mbikou et al., 2011; 
Mbikou et al., 2006) and add a small delay in force development after [Ca2+]i increase.  
4.3 Modelling of the MLCK/MLP balance and Ca
2+
-contraction coupling 
In our models (Fajmut et al., 2008; Fajmut et al., 2005b; Mbikou et al., 2011; Mbikou et al., 
2006) we showed that the transduction of the Ca2+ signal from its appearance in the cytosol 
as a time-dependent variation of concentration to the development of force in smooth 
muscle cells is decoded mainly by the interactions between Ca2+, CaM and MLCK, and is 
further translated to force by the balance between the phosphorylation and 
dephosphorylation of MLC, whereby both processes are regulated by MLCK and MLCP, 
respectively. The abundance of actomyosin crossbridges either phosphorylated or in the 
latch state is reflected in the magnitude of developed force. Our model results point out that 
a complete description of MLCK activation by Ca2+-CaM is necessary for the relevant 
prediction of Ca2+-contraction coupling and that 4-state latch bridge model upgraded with 
Ca2+-CaM-dependent MLCK activation well describes the fast phase (first few minutes) of 
force development in the isometric contraction of rat tracheal rings (Fajmut et al., 2008; 
Mbikou et al., 2011; Mbikou et al., 2006). 
Essentially, the last and the most elaborated version of the model describing Ca2+-
contraction coupling consists of three parts (Mbikou et al., 2011). The first one describes the 
activation of MLCK by Ca2+-CaM complexes, considers binding of MLCK to Ca2+-free CaM 
as well as to various Ca2+-CaM complexes, predicts the concentration of the active form of 
MLCK, i.e. the complex Ca4CaMMLCK, in dependence of [Ca2+]i. The kinetic scheme of 
these interactions is presented in Figure 5. 
The second part describes the regulation of MLCP activity and represents an essential 
upgrade from the original description of Hai and Murphy (Hai et al., 1988a), in which 
dephosphorylation velocity was taken as a linear function of AMP and MP. In our first 
models (Fajmut et al., 2008; Fajmut et al., 2005b; Mbikou et al., 2006) we treated 
dephosphorylation process with two parallel enzymatic reactions of Michaelis-Menten type 
with AMP and MP as the substrates for MLCP and with MLCP·MP and MLCP·AMP as the 
intermediate complexes. All these models considered constant total amount of the enzyme 
and one Ca2+ independent catalytic activity of MLCP. In accordance with recent 
experimental results indicating that the activity of MLCP is under the influence of Rho-
Kinase (RhoK) (Somlyo et al., 2000), we modelled RhoK-dependent MLCP regulation 
(Mbikou et al., 2011). RhoK phosphorylates MLCP and thus modifies its enzymatic 
properties. It decreases the rate constant of enzyme-substrate breakdown (kcat) and increases 
the Michaelis constant (KM) (Feng et al., 1999; Ichikawa et al., 1996; Lukas, 2004). The 
mechanisms by which RhoK is itself activated have not yet been fully determined. However, 
according to our present experimental results, RhoK is likely to be activated by the Ca2+ 
signal (Mbikou et al., 2011). Thus, we consider the transition of RhoK from inactive state into 
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active state to be Ca2+-dependent. On these statements, RhoK activity has been modelled 
according to the kinetic scheme, represented in Figure 7 (Mbikou et al., 2011).  
 
Fig. 7. Kinetic scheme of RhoK dependent MLCP phosphorylation and partial inhibition 
proposed by Mbikou et al. (Mbikou et al., 2011). RhoKi, inactive RhoK; RhoK*, active 
Rhok. MLCPi, inactive MLCP; MLCP*, active MLCP. 
RhoK can be either in an inactive (RhoKi) or active (RhoK*) state. k+RK and k-RK are the 
corresponding on- and off- rate constants. k+RK depends on the Ca2+ response, that is the 
[Ca2+]i above baseline. Modelling of MLCP phosphorylation by RhoK* is based on the 
steady-state Michaelis-Menten enzyme kinetics, whereby MLCP*RhoK* is the intermediate 
complex and kcatP is the rate constant for the breakdown of this intermediate complex into 
product, i.e. MLCPi. k+P and k-P are the corresponding overall rate constants for MLCP 
phosphorylation and dephosphorylation, respectively. The values of the rate constant of 
MLCP-substrate breakdown (kcat) and the Michaelis constant of MLCP (KM) depend on the 
net effective form of MLCP, which is dependent on the fraction of unphosphorylated and 
inhibited MLCP ([MLCP]*/[MLCP]i). 
The third part of the modelling represents the well-known 4-state actomyosin latch bridge 
model (Hai et al., 1988a). Links between all three parts of the model are the active form of 
MLCK and the net effective form of MLCP, which both modulate the rate of MLC 
phosphorylation and dephosphorylation.  
In our experimental and theoretical study (Mbikou et al., 2006), the version of the model 
without RhoK-dependent regulation of MLCP was first developed and analysed. The model 
was applied to the studies of the effect of different calcium signals to the amplitude and the 
velocity of force developed in airway smooth muscles. It was shown that the velocity and 
magnitude of the force that develops in several seconds after cholinergic stimulation are 
determined by the following signal parameters: the amplitude and the frequency of the 
oscillating Ca2+ signal as well as the plateau - but not the peak - in the biphasic Ca2+ signal, 
which comprises a peak followed by a decline to a plateau phase (Mbikou et al., 2006). On 
the other hand, the increased frequency of oscillating Ca2+ signal is translated into the 
increase of force magnitude (Fajmut et al., 2008; Mbikou et al., 2006). One main physiological 
implication of that model (Mbikou et al., 2006) was the prediction of the temporal delay of 
force generation with respect to Ca2+ transient. Figure 8 (left panel) presents the time 
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dependent relative MLC phosphorylation (p) (full line) and relative MLCK activity (A) 
(dotted line) after biphasic [Ca2+]i with a peak and a plateau with the characteristic values 
(peak: 0.6 µM, plateau: 0.2 µM, baseline: 0.15 µM) as well as the time dependent relative 
force development (F) as predicted by the model (Mbikou et al., 2006) (right panel). 
 
Fig. 8. Predicted MLCK activity and MLC20 phosphorylation. Left panel: Time dependent 
relative MLC phosphorylation (p) (full line) and relative MLCK activity (A) (dotted line) after 
biphasic [Ca2+]i with a peak and plateau as predicted by the model (Mbikou et al., 2006). Right 
panel: Time dependent relative force development (F) as predicted by the model (Mbikou et al., 
2006). F is defined relatively to the force obtained at supramaximal steady [Ca2+]i.   
This time-delay originates also from the process of MLCK activation/inactivation. Namely, 
the process of Ca2+-CaM-dependent MLCK activation contributes significantly to the time 
delay, in contrast with other studies (Kasturi et al., 1993; Torok et al., 1994), hypothesizing 
that the process of MLCK activation is extremely fast and is not likely to contribute more 
than a few milliseconds to the overall delay in force development (Sieck et al., 1998). Slow 
force generation in our model is also a consequence of the slow-rate of MLCK 
activation/inactivation kinetics. Additionally, the kinetics of formation of actomyosin cross 
bridges explains the delay between MLC phosphorylation and force development, and the 
Hill-shaped time course of isometric contraction. 
In another purely theoretical study (Fajmut et al., 2008) we confirmed that upon biphasic 
Ca2+-signal transduction through the system, MLCK controls amplitude more than duration, 
whereas MLCP tends to control both. These general characteristic regulatory properties of 
kinases and phosphatases were previously described by Heinrich et al. and Hornberg et al. 
(Heinrich et al., 2002; Hornberg et al., 2005) in other signalling processes. 
In our most recent work (Mbikou et al., 2011), the model was applied to the studies of RhoK 
contribution to the early phase of the Ca2+-contraction coupling in airway smooth muscle. 
For this purpose, the simulation of RhoK inhibitor Y27632 was simulated by the model. 
Theoretical results of early stress development agreed with experimental results, which 
showed an evident drop in the stress development after RhoK inhibition in the early phase 
of contraction, whereby the shape and the characteristic time of stress development did not 
change significantly. The model further predicted that maximal RhoK activation and 
subsequent MLCP inactivation occur in less than 10 s, i.e., before the short time maximal 
contraction is achieved (Mbikou et al., 2011). 
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An essential property of our models coupling Ca2+ and contraction is the explicit 
consideration of MLC phosphorylation and dephosphorylation steps described by 
Michaelis-Menten kinetics. This permits simulations of the effects that variations in  
enzyme contents and their catalytic properties exert on their velocities of 
phosphorylation/dephosphorylation, signal transduction and development of force. In this 
sense our models provide an upgrade with respect to the original Hai and Murphy's model 
as well as other models describing smooth muscle contraction. 
4.4 Modelling of thin filament-associated regulation of contraction 
An additional upgrade to the original Hai and Murphy's model has been proposed by Hai 
and Kim in 2005 (Fajmut et al., 2005c) to address some experimental data that could not be 
explained by the four-state model. Because in phorbol ester-induced force development 
constant myosin phosphorylation could not be explained by the original 4-state model, the 
authors proposed and postulated a thin-filament-regulated latch-bridge model that includes 
two latch-bridge 4-state cycles, one of which is identical to the original Hai and Murphy's 
model, and the other one is the ultraslow 4-state cycle with lower cross-bridge cycling rates 
(Hai et al., 2005). The model is able to fit phorbol ester-induced contractions at constant 
myosin phosphorylation. This was achieved by shifting cross bridges from the regular to the 
ultraslow cross-bridge cycle. It was also proposed that PKC activation leads to the thin-
filament-based inhibition of actomyosin ATPase activity in ultraslow cycle, however, 
authors did not specify the target, the signalling pathway and the mechanism of this 
regulation. They hypothesized about calponin and caldesmon – the thin-filament-based 
regulatory proteins – being the candidates for the inhibition of actomyosin ATPase activity 
caused by PKC, because both proteins can exist in the unphosphorylated and 
phosphorylated form (Gerthoffer et al., 1994).  
In the early 1990s it was believed that the actin bound proteins, calponin and caldesmon, 
have large modulatory role in the latch state, however, in the late 1990s, the discovery of the 
significant regulatory role of myosin light chain phosphatase in smooth muscle contraction 
draw attention away from the thin-filament-based regulatory proteins (Paul, 2009). There is 
evidence that regulation of the response to a given [Ca2+]i, that is, regulation of the ‘Ca2+ 
sensitivity’ via modulating phosphatase activity, is as important as regulation of [Ca2+]i in 
the control of contractility (Paul, 2009). PKC-mediated phosphorylation of CPI-17 has been 
postulated as a mechanism of PKC-mediated inhibition of MLCP (Hirano et al., 2003). 
However, according to Hai and Kim (Hai et al., 2005) this mechanism can potentially explain 
only the initial increase in the MLC phosphorylation but not the continued force 
development after myosin phosphorylation has already reached steady state.  
In our experimental studies (Mbikou et al., 2011; Mbikou et al., 2006) we also observed the 
biphasic force development similar to that observed by phorbol ester-induced contraction 
(Hai et al., 2005). The analysis of the time course of isometric contraction and MLC 
phosphorylation showed that the contractile response of rat tracheal rings to cholinergic 
stimulation developed in two distinct phases (Mbikou et al., 2006). The first, short-time 
contractile response, which represents 70 % of the total contraction, was associated with a 
fast [Ca2+]i peak followed by a plateau with, in some cases, with superimposed [Ca2+]i 
oscillations, in correlation with fast and transient MLC phosphorylation, and Hill-shaped 
force development (Mbikou et al., 2006) as shown in our model simulations presented in 
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Figure 8. The first fast phase was then followed by the second slow phase in which progressive 
increase of force reached plateau after 30 minutes (Mbikou et al., 2006). Our model (Mbikou et 
al., 2006) of force development generated by Ca2+-dependent MLCK activation properly 
predicted the short-time contractile response. Simulations with the existing model showed that 
the long-time contractile response might be explained either by a long-term increase in 
oscillation frequency or [Ca2+]i plateau. However, recordings of [Ca2+]i responses to cholinergic 
stimulation for several minutes did not support such a hypothesis (Perez et al., 2005). A 
possible explanation was, in parallel with the activation of MLCK, the inactivation of MLCP, 
which may be due to the action of PKC or RhoK (Mizuno et al., 2008). For RhoK we have 
recently shown that it is implicated only in the fast phase of force development (Mbikou et al., 
2011). However, incorporation of progressive slow inactivation of MLCP in our modelling 
predicts a time course of isometric contraction similar to the experimental one, and explains 
the second increase in MLC phosphorylation and a slow phase in force development (Mbikou 
et al., 2006). But, it does not explain a decrease in MLC20 phosphorylation associated with 
maximal force observed after 30 minutes (Mbikou et al., 2006).  
5. Conclusion 
In airway smooth muscle as in other smooth muscles, actin-myosin cross bridge cycling 
critically depends on the phosphorylation of MLC20 and hence on MLCK/MLCP balance. 
MLCK, which activity is modulated by the Ca2+ signal through the formation of the Ca2+-
calmodulin-MLCK complex, is the most important kinase in airway myocyte contraction and 
the contractile properties of airway smooth muscle cells are lost when MLCK is inactivated or 
deleted. However, though activation of MLCK is indispensable, contraction of airway smooth 
muscle, both in its amplitude and time-course, is modulated by a network of kinases that can 
act upstream the Ca2+ signal, modulating the Ca2+ signal itself, or downstream, modulating the 
sensitivity of the contractile apparatus to Ca2+. The main targets of the protein kinases acting 
on the decoding of the Ca2+ signal are MLCP and MLCK, though direct MLC20 
phosphorylation, in parallel to MLCK, may be possible. Indeed, MLCP and MLCK have 
several sites of phosphorylation and their enzymatic activity depends on whether these sites 
are phosphorylated or not. These phosphorylations may up- or downregulate MLCP and 
MLCK activity. Stimulation of airways by contractile agonists such as acetylcholine activates 
kinases such as Rho kinase and PKC that inhibit MLCP activity and hence increase the 
sensitivity of the contractile apparatus to Ca2+. By contrast, ┚2-adrenergic stimulation, a major 
relaxant pathway, activates PKA which inhibits MLCK and favours MLCP activity. 
Additionally, contraction may be modulated by phosphorylation of caldesmon and calponin, 
proteins associated with the thin filament of actin. The MLCK/MLCP balance is hence 
embedded in a network of protein kinases. The resultant contractile behaviour of the SMC 
depends on the dynamics of the reaction of this regulatory network, and mathematical 
modelling is essential to decipher how the different protein kinases determine the time-
dependent variation of the contractile status of the airway smooth muscle cell. 
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